Cancer Clinical Trial
Official title:
International Validation and Testing of a Supplementary Questionnaire Module for Assessment of Oral and Dental Health in Cancer; the QLQ-OH17
Assessment of oral and dental problems is seldom routine in clinical oncology, despite the
potential negative impact of these problems on nutritional status, social function and
quality of life (QoL). A brief, assessment tool for oral/dental health and related
QoL-issues to improve symptom management has been requested. The present study will be
conducted on behalf of and with support from the European Organisation for Research and
Treatment of Cancer - (EORTC) Quality of Life Group (QLG). The study represents phase IV,
the final step, in the development of an international, symptom specific questionnaire
module, focusing on oral and dental problems in relation to cancer and its treatment. Phase
I-III of this stepwise development process was conducted from 2008 to 2011, as an
international collaboration and conducted according to the guidelines for module development
set forth by the EORTC QLG. The resulting module, the QLQ-OH17, is now subject to an
international field testing and validation study as described in this project description.
The present version of the QLQ-OH17 consists of 17 items conceptualized into four multi-item
scales (pain/discomfort, xerostomia, eating and information) and three single items related
to use of dentures and future worries. The aim of the present study is to conduct phase IV;
an international field study to confirm the psychometric properties of the QLQ-OH17
The EORTC guidelines will be strictly followed also in phase IV of the module development.
Eligible patients will be contacted by the local study coordinator or a study nurse and
informed about the study. After having provided written informed consent, they will be
presented with the following two questionnaires for self-report of general symptoms,
specific dental and oral symptoms, and quality of life issues; the EORTC QLQ-C30 and the
QLQ-OH17. In addition to these two, a short debriefing interview will be conducted by study
coordinator / study nurse for assessment of feasibility and patients' opinion about the
questionnaires.
The case report form (CRF) on medical and demographic data will be completed by the study
coordinator / study nurse before or after the patients have completed their part.
A subset of the patients will be assessed twice, as examination of test - retest reliability
is important in phase IV of the development process.
;
Observational Model: Cohort, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|